Press Release RMTG’s Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets Aug 24
Press Release RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000 Aug 20
Press Release RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions Aug 19
Press Release RMTG Expands Cellgenic’s CancĂșn Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms Aug 18